Dr. Rachit Kumar
Claim this profileHarold Alfond Center for Cancer Care
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
46 drugs studied
Affiliated Hospitals
Clinical Trials Rachit Kumar is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
More about Rachit Kumar
Clinical Trial Related1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Rachit Kumar has experience with
- Pembrolizumab
- Ulixertinib (BVD-523)
- Atezolizumab And PHESGO
- Futibatinib
- Sunitinib
- Regorafenib
Breakdown of trials Rachit Kumar has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachit Kumar specialize in?
Rachit Kumar focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Rachit Kumar currently recruiting for clinical trials?
Yes, Rachit Kumar is currently recruiting for 3 clinical trials in Augusta Maine. If you're interested in participating, you should apply.
Are there any treatments that Rachit Kumar has studied deeply?
Yes, Rachit Kumar has studied treatments such as Pembrolizumab, Ulixertinib (BVD-523), Atezolizumab and PHESGO.
What is the best way to schedule an appointment with Rachit Kumar?
Apply for one of the trials that Rachit Kumar is conducting.
What is the office address of Rachit Kumar?
The office of Rachit Kumar is located at: Harold Alfond Center for Cancer Care, Augusta, Maine 04330 United States. This is the address for their practice at the Harold Alfond Center for Cancer Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.